Similar articles

• Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.

  Bahado-Singh RO, Wapner R, Thom E, Zachary J, Platt L, Mahoney MJ, Johnson A, Silver RK, Pergament E, Filkins K, Hogge WA, Wilson RD, Jackson LG; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening Study Group. Bahado-Singh RO, et al. Am J Obstet Gynecol. 2005 May;192(5):1357-61. doi: 10.1016/j.ajog.2004.12.086. Am J Obstet Gynecol. 2005. PMID: 15902108
• Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.

  McAuliffe FM, Hornberger LK, Winsor S, Chitayat D, Chong K, Johnson JA. McAuliffe FM, et al. Am J Obstet Gynecol. 2004 Oct;191(4):1486-90. doi: 10.1016/j.ajog.2004.05.049. Am J Obstet Gynecol. 2004. PMID: 15507988
• [Increased nuchal translucency at 11-14 weeks of gestation in congenital heart disease, genetic syndromes and adverse pregnancy outcome].

  Markov D, Chernev T, Dimitrova V, Mazneĭkova V, Loquet P. Markov D, et al. Akush Ginekol (Sofiia). 2005;44(6):8-15. Akush Ginekol (Sofiia). 2005. PMID: 18982826 Bulgarian.
• Nuchal translucency and fetal cardiac malformations.

  Axt-Fliedner R, Gembruch U. Axt-Fliedner R, et al. Ultraschall Med. 2010 Apr;31(2):144-50. doi: 10.1055/s-0028-1109702. Epub 2010 Jan 21. Ultraschall Med. 2010. PMID: 20094976 Review.
• Does nuchal translucency have a role in fetal cardiac screening?

  Hyett J. Hyett J. Prenat Diagn. 2004 Dec 30;24(13):1130-5. doi: 10.1002/pd.1070. Prenat Diagn. 2004. PMID: 15614845 Review.